Deployed >$1bn of capital into life science and healthcare ventures in his investor roles at Index, Medicxi, Bayer and Mubadala. Expert on drug discovery, cell & gene therapy and digital health ventures. Has been on both buy and sell sides of biotech-biopharma deals
Sign up to view 0 direct reports
Get started